JAK3/ BTk-in-1 is a dual JAK3/BTK inhibitor that specifically targets and inhibits Janus kinase 3 (JAK3) and Brutons tyrosine kinase (BTK), two important targets in autoimmune diseases. JAK3/ BTk-in-1 simultaneously inhibited the BTK/JAK3 signaling pathway, showing a synergistic effect. JAK3/ BTK-in-1 is a potential compound for the treatment of immune-related diseases, such as autoimmune diseases, certain types of cancer (including lymphoma and leukemia), and other diseases that may be characterized by an unbalanced immune response.
Molecular Weight:
456.54
Purity:
97.89%
CAS Number:
[2674036-91-8]
Formula:
C25H28N8O
Target:
BTK|||JAK
T9814
* VAT and and shipping costs not included. Errors and price changes excepted